The purpose of this study is to see if rosuvastatin compared to Atorvastatin is effective in treating ACS by decreasing the ApoB/ApoA-1 ratio and if starting statin within 24 h following the onset of the first symptoms is beneficial compared to placebo.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
1,160
Percentage changes in ApoB/ApoA-I levels
Time frame: from Day 0 to 3 months
Percentage changes in LDL-C
Time frame: from Day 0 to 1 month and 3 months
Percentage changes in the hs-CRP and AUC of hs-CRP levels
Time frame: from Day -6 to Day 0
Percentage changes in ApoA-I
Time frame: from Day 0 to 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Aalst, Belgium
Research Site
Bonheiden, Belgium
Research Site
Bouge, Belgium
Research Site
Brussels, Belgium
Research Site
Charleroi, Belgium
Research Site
Hasselt, Belgium
Research Site
Huy, Belgium
Research Site
La Louvière, Belgium
Research Site
Leuven, Belgium
Research Site
Edmonton, Alberta, Canada
...and 92 more locations